Faculty Information   
   日本語 >>
  1. TOP page
    2. >
  2. Clinical Medicine Seminars
    3. >
  3. Division of Gastroenterology Department of Internal Medicine

Journal
Presentation
    （Last updated : 2022-07-02 10:28:47）
  Kamikozuru Koji
   Department   Specialty Division  , Clinical Medicine Seminars
   Position  
■ Journal
1. Original article　 Looking for predictive factors of clinical response to adsorptive granulocyte and monocyte apheresis in patients with ulcerative colitis: markers of response to GMA. 2013/05
2. Original article　 Questionnaire based assessment of patients' acceptability of leukocytapheresis for the treatment of inflammatory bowel disease. 2013/10
3. Original article　 Prospective postsurgical capsule endoscopy in patients with Crohn's disease 2014/03
4. Original article　 Crohn's disease complicated by hepatitis B virus successfully treated with the use of adsorptive depletion of myeloid lineage leucocytes to suppress inflammatory cytokine profile. 2014/06
5. Original article　 A novel gas chromatography mass spectrometry-based serum diagnostic and assessment approach to ulcerative colitis. 2014/09
6. Original article　 Granulomonocytapheresis as a cell-based therapy in an ulcerative colitis patient complicated by aminosalicylate-induced severe lymphocytopenia and pneumonia. 2016/09
7. Original article　 Genetic instability, CpG island methylator phenotype, and proliferative activity are distinct differences between diminutive and small tubular adenoma of the colorectum. 2016/10 Link
8. Original article　 NUDT15, FTO, and RUNX1 genetic variants and thiopurine intolerance among Japanese patients with inflammatory bowel diseases. 2017/07
9. Original article　 Inflammatory bowel disease patients experiencing a loss of response to infliximab regain long-term response after undergoing granulocyte/monocyte apheresis: A case series. 2017/12
Display 5 items
Display all(9)
■ Presentation
1. Capsule endoscopy for assessing small bowel residual lesions at resection and postsurgical recurrence in Crohn's disease  2012/12
2. Clinical features of bamboo joint like appearance at the gastric body and cardia,notches in the duodenum with crohn,s disease  2013/01/26
3. Association between autoantibodies against the gastric proliferative zone and inflammatory bowel disease  2013/02/15
4. Looking for predictive factors of clinical response to adsorptive granulocyte and monocyte apheresis in patients with ulcerative colitis  2013/02/15
5. Predictive factors of refractory to tacrolimus therapy in patients with active ulcerative colitis  2013/02/15
6. A randomized, double-blind, placebo-controlled study of rebamipide for gastric mucosal injury in subjects taking low-dose aspirin with or without clopidogrel  2013/05/18
7. Effectiveness of a new type ultrathin colonoscope in colonoscopy of patients with active ulcerative colitis  2013/05/18
8. The predictive factors for refractory status and readmission after tacrolimus treatment in patients with active ulcerative colitis  2013/05/21
9. Efficacy of infliximab in pediatric crohn's disease patinets.  2013/06/13
10. The Processed Blood Volume per Body Weight for Granulocyte and Monocytes Adsorption Session in Patients with Crohn,s Disease  2013/10/16
11. A report on the prevalence and reactivation rate of hepatitis B virus in patients with inflammatory bowel disease in Japan  2014/02/21
12. α Infliximab remission induction therapy in patients with ulcerative colitis: Does tumour necrosis factor- α receptor blockade per se explain its multiple actions?  2014/02/21
13. A report on the prevalence and reactivation rate of hepatitis b virus in patients with inflammatory bowel disease in Japan  2014/05/03
14. Incidence and Severity of Acute Kidney Injury During Oral Tacrolimus Treatment in Patients With Refractory Ulcerative Colitis  2015/05/16
15. The Outcome of 142 Endoscopic Balloon Dilatations of Ileocaecal and Colonic Strictures in Patients With Crohn's Disease Patients  2015/05/16
16. THE CLINICAL OUTCOMES OF 165 ENDOSCOPIC BALLOON DILATATION FOR ILEOCOLONIC OR CAECAL STRICTURES IN PATIENTS WITH CROHN'S DISEASE  2015/10/28
17. Long term efficacy and safety of thiopurines in patients with steroid dependent Ulcerative Colitis: A retrospective investigation  2016/03/18
18. Pregnancy outcomes in patients with Inflammatory Bowel Disease experiencing flare ups during foetal development  2016/03/18
19. Proximal extension of distal lesions in patients with Ulcerative Colitis  2016/03/18
20. The efficacy of infliximab in tacrolomus non-responder with UC  2016/03/18
21. Pregnancy Outcomes in Patients with Inflammatory Bowel Disease Experiencing Flare ups During Foetal Development  2016/05/22
22. Factors Associated With Restenosis and the Need for Surgical Interventions in Patients With Crohn`s Disease Undergoing Endoscopic Balloon Dilatation for Lower Gastrointestinal Strictures  2016/05/23
23. Long Term Efficacy and Safety of Thiopurines in Patients With Steroid Dependent Ulcerative Colitis: A Retrospective Investigation  2016/05/23
24. The endoscopic feature of relapse in ulcerative colitis treated with infliximab.  2016/07/08
25. Genetically-Determined Increases in LRRK2 Levels enhance susceptibility to colitis  2016/07/09
26. Pregnancy complications and outcomes in patients with Inflammatory Bowel Disease  2017/02/17
27. Efficacy of Adsorptive Granulocyte/Monocyte Apheresis in Inflammatory Bowel Disease Patients Experiencing Loss of Response to Infliximab:A Case Series.  2017/06/17
28. Thiopurine-induced Leukopenia Is Associated with a Variant in NUDT15, but Not FTO and RUNX1 in Japanese Patients with Inflammatory Bowel Diseases.  2017/06/17
29. LRRK2 Inhibitor Attenuates Intestinal Inflammation and Becomes a Therapeutic Strategy in Inflammatory Bowel Diseases  2017/07/21
30. Clinical and endoscopic features of secondary loss of response caases in patients with Crohns disease treated with infliximab by top down strategy a case control study  2018/02/16
31. Clinical characteristics and complications in hospitalised elderly patients with ulcerative colitis in a real world specialised hospital  2018/02/16
32. CLINICAL CHARACTERISTICS AND COMPLICATIONS IN HOSPITALISED ELDERLY PATIENTS WITH ULCERATIVE COLITIS IN A REAL-WORLD SPECIALISED HOSPITAL  2018/06/04
33. THE INITIAL TROUGH CONCENRTATION AT 36 HOURS AFTER STARTING TACROLIMUS IS IMPORTANT FOR THE PERSONALIZED MEDICINE STRATEGY IN PATIENTS WITH ULCERATIVE COLITIS  2018/06/04
34. Clinical features of ulcerative colitis complicated by autoimmune hepatitis: a case series in Japan  2018/06/22
35. Efficacy and related issues of cytapheresis in elderly patients with ulcerative colitis  2018/06/22
36. Endoscopic features for loss of response in patients with Crohn’s disease who were treated with infliximab by top-down strategy.  2019/03/08
37. Investigations of the characteristics and efficary of anti-TNFα agents for optimizing treatment in pediatric patients with new-onset Crhon’s disease.  2019/03/08
38. Risk factors and clinical characteristics for Pneumonia in Japanese Patients with Ulcerative Colitis.  2019/03/08
39. The initial trough concentration at 36 hours after starting tacrolimus is important for the personalized medicine strategy in patients with ulcerative colitis.  2019/03/08
40. CLINICAL CHARACTERISTICS AND RISK FACTORS FOR PNEUMOCYSTIS JIROVECII PNEUMONIA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE.  2019/05/19
41. Investigations of the characteristics and anti-TNFα agents for optimizing treatment in pediatric patients with new-onset Crohn’s disease.  2019/05/19
42. EFFICACY AND SAFETY OF TOFACITINIB TREATMENT FOR 1 YEAR IN JAPANESE PATIENTS WITH ULCERATIVE COLITIS IN A SPECIALIZED IBD CENTER.  2021/05/22
43. Efficacy and safety of tofacitinib treatment for one year in Japanese patients with Ulcerative Colitis in a specialized Inflammatory Bowel Disease center.  2021/07/08
44. EFFICACY AND SAFETY OF TOFACITINIB TREATMENT FOR 1 YEAR IN PATIENTS WITH ULCERATIVE COLITIS IN A SPECIALIZED IBD CENTER.  2021/11/13
Display 5 items
Display all(44)
mail